Specific Overview
- Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
68
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$370M
Specific General Information
Description
Developer of diagnostic equipment designed to streamline lab workflows in determining the effectiveness of antibiotics in treating sepsis. The company's product includes an instrument and assay that responds to the metabolic byproducts produced by microorganisms to detect growth, assess antibiotic efficacy, and determine microorganism ID, enabling doctors to shorten the time from sample arrival to a selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections.
Contact Information
Primary Office
- 130 Baytech Drive
- San Jose, CA 95134
- United States
+1 (650) 000-0000
Specific Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 19-May-2022 | $370M | 000.00 | 00000 | Completed | Generating Revenue |
| 6. Grant | 02-Jun-2020 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series A) | 06-Sep-2019 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Grant | 07-Aug-2019 | 00.00 | Completed | Generating Revenue | ||
| 3. Grant | 07-Feb-2017 | 00000 | Completed | Generating Revenue | ||
| 2. Grant | 01-Jan-2017 | $3.99M | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2013 | $145K | Completed | Generating Revenue |
Specific Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 |
Specific Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of diagnostic equipment designed to streamline lab workflows in determining the effectiveness of antibiotics i
Diagnostic Equipment
San Jose, CA
68
As of 2022
000.00
0000
0000-00-00
000000&0
000.00
000000
strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000 000000000
Cincinnati, OH
000
As of 0000
0.000
0000-00-00
000000&0
000000
psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididu
0000000000000
Hayward, CA
000
As of 0000
0000
00000000000
0000
Add Comparison
Specific Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Meridian Bioscience | Private Equity-Backed | Cincinnati, OH | 000 | 000000&0 | ||
| 000000 | Venture Capital-Backed | Hayward, CA | 000 | 0000 | 00000000000 | 0000 |
Specific Executive Team (5)
Specific Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kenneth Suslick Ph.D | Specific | Member of US Scientific Advisory Board | 000 0000 |
| Paul Grossman Ph.D | Telegraph Hill Partners | Board Member | 000 0000 |
Specific Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Specific Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CARB-X | University | 000 0000 | 000000 0 | ||
| National Institute for Allergy and Infectious Disease | Government | 000 0000 | 000000 0 | ||
| Telegraph Hill Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |